Leader in Phase 1 Clinical Research & Pharmacology

Delivering Early Phase Confidence Through Expertise and Experience

Celerion collaborates with emerging and established Pharmaceutical and Biotechnology companies during the pathway for drug approval, with rapid and safe progression to Clinical Proof-of-Concept. With 50+ years of experience and more than 650 beds in North America and Europe, we offer the largest and most experienced global early phase clinical operations in the industry. Our breadth of capabilities, coupled with purpose-built facilities, including co-located pharmacy, clinical laboratories and flexible conduct areas, ensure your study is completed with the highest quality and on time. You will benefit by access to quality data earlier in the drug development process.

Celerion Gives You Confidence

When you tap into Celerion Science^SM you benefit from our experience in managing more than 6000 clinical research studies, enabling you to have the confidence that your study will be completed quickly and accurately. We are experts at one of the most challenging aspects of clinical studies: finding the right subjects. Celerion has experience with the most complex Phase I trials using specialized procedures such as echocardiograms, CSF collection, cognitive testing, imaging, PBMC processing, semen collection, and bronchoalveolar lavage.

Effective and Faster Decision Making

We generate strategies that minimize the time to key go/no-go decisions by leveraging its clinic facilities, biomarker analysis capabilities, PK/PD analysis skills and program planning experience. We have actively invested in new technologies to enrich data collection and analysis and to expedite data delivery to our clients.

• A leader in cardiovascular safety services, our highly automated ECG Core Lab enables fast access to data and cost-effective solutions of thorough QT studies and intensive ECG assessments early in your clinical development.
• A 24-bed clinic located within a hospital brings access to medical specialists, imaging capabilities and intensive medical support for those studies that require specialized care and procedures.
• Our USP <797> Clean Room enables microtracer and microdosing studies as well as for all types of complex extemporaneous compounding for low, medium and high risk investigational compounds.
• Our Lincoln, Nebraska facility is licensed to handle radiolabeled compounds for human mass balance studies with more than 30 years’ experience. On-site scintillation counting is completed real-time to allow for accurate and timely release of subjects.